Mortality and Institutionalization After Percutaneous Endoscopic Gastrostomy in Parkinson's Disease and Related Conditions.
PEG
Parkinson's disease
institutionalization
percutaneous endoscopic gastroscopy
tube feeding
Journal
Movement disorders clinical practice
ISSN: 2330-1619
Titre abrégé: Mov Disord Clin Pract
Pays: United States
ID NLM: 101630279
Informations de publication
Date de publication:
Jul 2020
Jul 2020
Historique:
received:
15
01
2020
revised:
26
02
2020
accepted:
28
03
2020
entrez:
7
7
2020
pubmed:
7
7
2020
medline:
7
7
2020
Statut:
epublish
Résumé
Percutaneous endoscopic gastrostomy (PEG) can facilitate feeding and medication administration in dysphagic patients with Parkinson's disease and related disorders. Information on survival, institutionalization, and complications post PEG might inform feeding decisions. A total of 93 patients with Parkinson's disease and related disorders were identified by review of PEG registers and by searching the administrative databases in 2 large UK university hospitals (2005-2017); 83 case notes were available for retrospective review. Care processes and outcomes were assessed. The following were the diagnoses: 58 (70%) had Parkinson's disease, 10 (12%) had progressive supranuclear palsy, 5 (6%) had multiple system atrophy, 3 (4%) had dementia with Lewy bodies, and 7 (8%) had vascular parkinsonism. The median age was 78 years (interquartile range 72-82); 29 (35%) were women. Care processes included a future care plan in place prior to admission for 18 patients (22%), and PEG was placed during emergency admission in 68 patients (82%). The outcomes included median survival at 422 days; 30-day mortality rate was 6% (5 patients); and of 56 patients admitted from home, 18 (32%) were discharged to institutions (nursing or care homes). The most common complication was aspiration pneumonia for 18 (22%) of patients. Age, sex, diagnosis, admission type, comorbidities, and place of residence did not predict survival. Discharge to own home and follow-up by the home enteral feeding team were associated with longer survival. We recommend markers of advanced disease should prompt advanced care planning. Discussions about PEG feeding should include information about post-PEG survival, complications, and risk of institutionalization. Further research is needed on quality-of-life post PEG and ways to reduce aspiration pneumonia. All PEG patients should have nutrition team follow-up.
Sections du résumé
BACKGROUND
BACKGROUND
Percutaneous endoscopic gastrostomy (PEG) can facilitate feeding and medication administration in dysphagic patients with Parkinson's disease and related disorders. Information on survival, institutionalization, and complications post PEG might inform feeding decisions.
METHOD
METHODS
A total of 93 patients with Parkinson's disease and related disorders were identified by review of PEG registers and by searching the administrative databases in 2 large UK university hospitals (2005-2017); 83 case notes were available for retrospective review. Care processes and outcomes were assessed.
RESULTS
RESULTS
The following were the diagnoses: 58 (70%) had Parkinson's disease, 10 (12%) had progressive supranuclear palsy, 5 (6%) had multiple system atrophy, 3 (4%) had dementia with Lewy bodies, and 7 (8%) had vascular parkinsonism. The median age was 78 years (interquartile range 72-82); 29 (35%) were women. Care processes included a future care plan in place prior to admission for 18 patients (22%), and PEG was placed during emergency admission in 68 patients (82%). The outcomes included median survival at 422 days; 30-day mortality rate was 6% (5 patients); and of 56 patients admitted from home, 18 (32%) were discharged to institutions (nursing or care homes). The most common complication was aspiration pneumonia for 18 (22%) of patients. Age, sex, diagnosis, admission type, comorbidities, and place of residence did not predict survival. Discharge to own home and follow-up by the home enteral feeding team were associated with longer survival.
CONCLUSION
CONCLUSIONS
We recommend markers of advanced disease should prompt advanced care planning. Discussions about PEG feeding should include information about post-PEG survival, complications, and risk of institutionalization. Further research is needed on quality-of-life post PEG and ways to reduce aspiration pneumonia. All PEG patients should have nutrition team follow-up.
Identifiants
pubmed: 32626795
doi: 10.1002/mdc3.12971
pii: MDC312971
pmc: PMC7328413
doi:
Types de publication
Journal Article
Langues
eng
Pagination
509-515Informations de copyright
© 2020 International Parkinson and Movement Disorder Society.
Références
Clin Nutr. 2005 Oct;24(5):848-61
pubmed: 16261664
Dysphagia. 2016 Feb;31(1):24-32
pubmed: 26590572
J Neurol Neurosurg Psychiatry. 2017 May;88(5):402-411
pubmed: 28250027
Curr Opin Clin Nutr Metab Care. 2002 Jan;5(1):35-42
pubmed: 11790947
Am J Crit Care. 2006 Jul;15(4):360-9
pubmed: 16823013
J Clin Neurosci. 2013 Feb;20(2):220-3
pubmed: 23228657
Food Nutr Res. 2011;55:
pubmed: 21799666
Arch Intern Med. 2003 Jun 9;163(11):1351-3
pubmed: 12796072
Parkinsonism Relat Disord. 2017 Oct;43:110-113
pubmed: 28781200
Age Ageing. 2009 Sep;38(5):617-9
pubmed: 19628680
Otolaryngol Clin North Am. 2009 Feb;42(1):87-105, ix
pubmed: 19134493
Clin Endosc. 2017 May;50(3):270-278
pubmed: 27737522
J Hum Nutr Diet. 2007 Dec;20(6):513-22; quiz 523-5
pubmed: 18001372